[22] [23] Separate NICE technology appraisals cover GLP-1 receptor agonists for weight management in specific patient groups
Advancing Type 1 Diabetes Management: Integrating Novel Therapies, Technologies, and Adjunctive Approaches
By focusing on a personalized approach that includes medical supervision, proper nutrition, and muscle-preserving exercise, you can work toward your weight goals while staying committed to your primary health treatments
As a community, we are stronger together
In this work, we investigate the molecular mechanisms by which GLP-1, oxyntomodulin, exendin-4, and exendin-P5 bind and activate the GLP-1R using a combination of structural biology, molecular dynamics simulations, and pharmacological studies combined with extensive receptor mutagenesis